|
KIAA0562 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06130000010474E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94689999999387E-06 |
| Normal-vs-Stage2 |
1.977470E-03 |
| Normal-vs-Stage3 |
3.84120000029853E-07 |
| Normal-vs-Stage4 |
3.59069999955608E-07 |
| Stage1-vs-Stage2 |
6.562800E-01 |
| Stage1-vs-Stage3 |
1.906190E-01 |
| Stage1-vs-Stage4 |
1.103990E-01 |
| Stage2-vs-Stage3 |
2.102800E-01 |
| Stage2-vs-Stage4 |
1.447430E-01 |
| Stage3-vs-Stage4 |
7.442200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.79979999979241E-07 |
| Normal-vs-AfricanAmerican |
4.207300E-04 |
| Normal-vs-Asian |
6.04159999999521E-05 |
| Caucasian-vs-AfricanAmerican |
6.700000E-01 |
| Caucasian-vs-Asian |
7.662600E-01 |
| AfricanAmerican-vs-Asian |
9.221400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.59540000496972E-08 |
| Normal-vs-Female |
1.0201000000265E-06 |
| Male-vs-Female |
1.715030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.4951999999987E-05 |
| Normal-vs-Age(41-60Yrs) |
5.35550000013707E-07 |
| Normal-vs-Age(61-80Yrs) |
1.31209999976178E-07 |
| Normal-vs-Age(81-100Yrs) |
6.680700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.997230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.721360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.828400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.157000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.552400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.643800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.143800E-01 |
| Classical-VS-Follicular |
1.755800E-01 |
| Classical-VS-Other |
1.813400E-01 |
| Classical-VS-Normal |
3.24870000001365E-06 |
| Tall-VS-Follicular |
9.215400E-01 |
| Tall-VS-Other |
3.459400E-01 |
| Tall-VS-Normal |
7.73270000000714E-05 |
| Follicular-VS-Other |
4.402200E-01 |
| Follicular-VS-Normal |
1.55016999999757E-05 |
| Other-VS-Normal |
2.736700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.73700000014743E-07 |
| Normal-vs-N1 |
1.83139999998527E-06 |
| N0-vs-N1 |
2.907800E-01 |
|
|
